Asymptomatic Versus Symptomatic Alzheimer's Disease Neuropathology: A Systematic Review of Differences Reported in Post‐Mortem Studies
Neuropathology and Applied Neurobiology · 2026-06 · 52 (3)
DOI: 10.1111/nan.70077 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Neuropathology and Applied Neurobiology, online erschienen am 08.05.2026. Verfasst von Thiago Guilherme Rêgo Barros und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório Integrado de Pesquisas em Patologia, Departamento de Patologia, Faculdade de Medicina, Universidade Federal de Juiz de Fora, Juiz de Fora…. Hauptthemen laut MEDLINE: Alzheimer Disease, Brain. Die Arbeit nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado de Minas Gerais, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES).
Themen: Demenz
Abstract (Originalsprache)
A subset of individuals exhibit substantial Alzheimer's disease ( AD ) neuropathology but remain asymptomatic (ASYMAD). The biological processes underlying this phenomenon remain poorly understood. We searched the PubMed/MEDLINE, Web of Science and CAPES databases to synthesise post‐mortem brain tissue findings that differ between symptomatic and asymptomatic AD . Thirty‐four studies met the predefined eligibility criteria. Multiple reports described lower levels of oligomeric Aβ and p‐tau in ASYMAD, with reduced accumulation at synapses. Consistent with synaptic resilience, ASYMAD showed preserved expression of markers and proteomic signatures linked to synaptic function, homeostasis and plasticity. Further analyses supported preserved parenchymal architecture and dendritic and axonal morphology in ASYMAD. Some authors also described compensatory adaptations, including neuronal hypertrophy, increased neurogenesis and cellular antioxidant responses in ASYMAD brains. Additional findings indicated partial resistance to disruption of brain glucose, polyunsaturated fatty acid and one‐carbon/polyamine metabolism. Glial and immune findings suggested a profile characterised by increased glial reactivity in specific regions and disease stages, alongside preserved glial homeostasis and lower cytokine expression in other contexts. In conclusion, although this review identified multiple processes potentially associated with the ASYMAD phenotype, the current evidence remains largely descriptive. Additionally, this synthesis is limited by substantial methodological heterogeneity and inconsistencies in data reporting. Future research should prioritise standardised clinicopathological definitions, pathology stage matching between ASYMAD and symptomatic AD groups, systematic assessment of mixed pathologies and further replication of exploratory findings to better elucidate the mechanisms underlying clinical resilience to AD neuropathology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratório Integrado de Pesquisas em Patologia, Departamento de Patologia, Faculdade de Medicina, Universidade Federal de Juiz de Fora, Juiz de Fora, Brazil.
- The Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, Lozano Long School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
- Laboratório de Neurobiologia "Conceição Machado", Departamento de Morfologia, Instituto de Ciência Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
ORCID-Profile: Thiago Guilherme Rêgo Barros, Laura Barbosa Grossi, Maria Letícia da Silva Campos, Israel Bem-Hur Netto Cardoso, Antônio Lúcio Teixeira, Aline Silva de Miranda, Eliana Cristina de Brito Toscano
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
Zitieren
APA
Barros, T. G. R., Grossi, L. B., da Silva Campos, M. L., Cardoso, I. B. N., Teixeira, A. L., de Miranda, A. S., & de Brito Toscano, E. C. (2026). Asymptomatic Versus Symptomatic Alzheimer's Disease Neuropathology: A Systematic Review of Differences Reported in Post‐Mortem Studies. Neuropathology and Applied Neurobiology, 52(3). https://doi.org/10.1111/nan.70077
Vancouver
Barros TGR, Grossi LB, da Silva Campos ML, Cardoso IBN, Teixeira AL, de Miranda AS, et al. Asymptomatic Versus Symptomatic Alzheimer's Disease Neuropathology: A Systematic Review of Differences Reported in Post‐Mortem Studies. Neuropathology and Applied Neurobiology. 2026;52(3). doi:10.1111/nan.70077
BibTeX
@article{Barros2026,
author = {Barros, Thiago Guilherme Rêgo and Grossi, Laura Barbosa and da Silva Campos, Maria Letícia and Cardoso, Israel Bem-Hur Netto and Teixeira, Antônio Lúcio and de Miranda, Aline Silva and de Brito Toscano, Eliana Cristina},
title = {Asymptomatic Versus Symptomatic Alzheimer's Disease Neuropathology: A Systematic Review of Differences Reported in Post‐Mortem Studies},
journal = {Neuropathology and Applied Neurobiology},
year = {2026},
volume = {52},
number = {3},
doi = {10.1111/nan.70077}
}
EUVIMED